NASDAQ$ACTG
Acacia Research Corporation · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
Acacia Research's financial performance reflected revenue growth driven by the Printronix acquisition, offset by net losses due to unrealized losses on equity securities, while also making progress on share repurchases and receiving FDA approval for Mycovia Pharmaceuticals' drug.
Acacia Research reported a revenue of $13.5 million, up from $5.8 million in the same quarter last year, which includes $10.9 million from Printronix. The company experienced a GAAP Net Loss of $73.3 million, or ($1.61) per diluted share, compared to a net loss of $164.5 million, or ($2.81) per diluted share, in the first quarter of last year. The company completed $15.0 million of share repurchases and anticipates receiving a $26 million milestone payment from Mycovia Pharmaceuticals.
- Total revenues were $13.5 million, compared to $5.8 million in the same quarter last year, including $10.9 million from Printronix.
- Recorded $66.9 million in realized gains during the quarter, including $59.5 million from the Life Sciences Portfolio.
- Completed $15.0 million of share repurchase under authorization announced in December 2021, repurchasing 3.1 million shares at an average price of $4.80.
- GAAP Net Loss of $(73.3) million, or ($1.61) per diluted share, compared to net loss of $(164.5) million, or $(2.81) per diluted share, in the first quarter of last year.
Headline financials
Revenue & EPS history
Acacia · Revenue · Quarterly
$13.5M
Revenue by segment
Acacia · $13.5M total across 2 segments · Q1 2022
- Industrial Operations$10.9M—80.6%
- Intellectual Property Operations$2.62M—19.4%
Forward guidance
Acacia anticipates attractive acquisition opportunities due to dislocations in the capital markets, leveraging its strong capital position and partnership with Starboard Value, LP.
Tailwinds
- Strong capital position
- Team of seasoned M&A professionals
- Strategic partners at Starboard Value, LP
- Attractive acquisitions
- Stock represents attractive value relative to book value
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2022
-1.1%
Avg return
Earnings day
+0.8%
Avg return
5 days after
+2.8%
Avg return
30 days after
42%
27 / 65 earnings
Positive
+20.7%
Q4 2025
Best reaction
-27.2%
Q1 2013
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -7.3% | -7.5% | -8.9% | |
| Q4 2025 | +20.7% | +18.8% | +18.1% | |
| Q3 2025 | +9.4% | +11.3% | +12.8% | |
| Q1 2025 | +15.7% | +26.4% | +24.8% | |
| Q4 2024 | -14.5% | -18.5% | -31.0% | |
| Q3 2024 | -8.9% | -6.3% | -4.9% | |
| Q2 2024 | -4.8% | -6.9% | -2.5% | |
| Q1 2024 | -1.9% | +2.1% | +0.2% | |
| Q4 2023 | +16.3% | +26.3% | +25.5% | |
| Q3 2023 | +1.7% | +3.0% | +6.1% | |
| Q2 2023 | -7.2% | -3.2% | -5.5% | |
| Q1 2023 | -1.2% | +0.8% | +14.5% | |
| Q4 2022 | -7.5% | -5.9% | -16.7% | |
| Q3 2022 | +2.0% | +0.0% | -5.3% | |
| Q2 2022 | -3.0% | -6.0% | -16.1% | |
| Q1 2022 | -3.9% | -1.3% | -0.9% | |
| Q4 2021 | +12.3% | +8.4% | +12.2% | |
| Q3 2021 | +5.3% | -3.1% | -10.2% | |
| Q2 2021 | -4.9% | -4.3% | +9.7% | |
| Q1 2021 | -5.1% | +0.5% | +12.6% | |
| Q4 2020 | +0.7% | +5.3% | +0.8% | |
| Q3 2020 | +1.4% | -2.5% | +0.0% | |
| Q2 2020 | -1.0% | -3.4% | -7.7% | |
| Q1 2020 | -0.2% | -8.6% | +62.9% | |
| Q4 2019 | +3.6% | -0.5% | +14.0% | |
| Q3 2019 | +14.2% | +13.0% | +13.8% | |
| Q2 2019 | -3.6% | -4.9% | -14.4% | |
| Q1 2019 | +1.0% | +1.0% | -0.6% | |
| Q4 2018 | -3.2% | -1.9% | -1.0% | |
| Q3 2018 | +2.7% | +1.3% | +3.7% | |
| Q2 2018 | +2.6% | +2.6% | -7.9% | |
| Q1 2018 | +1.4% | +1.4% | +5.5% | |
| Q4 2017 | -1.4% | -1.4% | +2.8% | |
| Q3 2017 | +6.1% | +9.8% | +4.9% | |
| Q2 2017 | -10.0% | -15.0% | -17.5% | |
| Q1 2017 | -4.9% | -3.9% | -22.5% | |
| Q4 2016 | -9.6% | -11.3% | -3.5% | |
| Q3 2016 | +1.7% | -2.5% | +24.4% | |
| Q2 2016 | +7.6% | +17.5% | +16.7% | |
| Q1 2016 | +4.1% | — | — | |
| Q4 2015 | -21.8% | — | — | |
| Q3 2015 | -14.4% | — | — | |
| Q2 2015 | +9.1% | — | — | |
| Q1 2015 | +12.9% | — | — | |
| Q4 2014 | -3.6% | — | — | |
| Q3 2014 | +1.2% | — | — | |
| Q2 2014 | +16.8% | — | — | |
| Q1 2014 | -0.2% | — | — | |
| Q4 2013 | -6.1% | — | — | |
| Q3 2013 | -25.3% | — | — | |
| Q2 2013 | -12.4% | — | — | |
| Q1 2013 | -27.2% | — | — | |
| Q4 2012 | +3.8% | — | — | |
| Q3 2012 | -0.2% | — | — | |
| Q2 2012 | +1.1% | — | — | |
| Q1 2012 | +2.3% | — | — | |
| Q1 2010 | -2.9% | — | — | |
| Q1 2011 | -2.9% | — | — | |
| Q4 2011 | -2.9% | — | — | |
| Q4 2009 | -2.9% | — | — | |
| Q3 2011 | -6.9% | — | — | |
| Q3 2010 | -6.9% | — | — | |
| Q2 2011 | -1.8% | — | — | |
| Q2 2010 | -1.8% | — | — | |
| Q4 2010 | -1.8% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro